Nello Mainolfi
Chief Executive Officer at Kymera Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Kymera Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Kymera Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2024 | Kymera Therapeutics Inc. | Option exercise | +18,773 | $5.33 | $100,060 |
| Jun 18, 2024 | Kymera Therapeutics Inc. | Option exercise | +14,413 | $2.08 | $29,979 |
| Jan 2, 2024 | Kymera Therapeutics Inc. | Option exercise | +9,000 | $2.08 | $18,720 |
| Nov 3, 2023 | Kymera Therapeutics Inc. | Option exercise | +2,368 | $2.08 | $4,925 |
| Nov 3, 2023 | Kymera Therapeutics Inc. | Option exercise | +17,632 | $2.08 | $36,675 |
| Aug 8, 2023 | Kymera Therapeutics Inc. | Option exercise | +12,000 | $2.08 | $24,960 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.